Drupal.behaviors.print = function(context) {window.print();window.close();}>

Alnylam Releases Preclinical Data Showing Efficacy of TTR Amyloidosis Rx Candidate

November 05, 2009

Alnylam Releases Preclinical Data Showing Efficacy of TTR Amyloidosis Rx Candidate

The company said that it expects to begin clinical testing of the drug in early 2010.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories